drugset / Trial / NCT00377078

Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.

NCT00377078 ↗

RandomizedCrossoverDouble-blindPrevention

Summary

Primary objective of this pilot study is to evaluate the effect of recombinant human lactoferrin on the rate of infection with Clostridium difficile in long-term care patients supported by enteral feeding requiring broad spectrum antibiotics.

Timeline

Start
2005-10
Primary completion
—
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Recombinant Human Lactoferrin Protein / enzyme biologic 3 g Other